Navigation Links
Takeda Responds to Verdict in Diabetes Drug Case
Date:4/26/2013

on

WARNING: HEART FAILURE
ACTOS can cause or worsen heart failure. ACTOS can cause the body to keep extra fluid (fluid retention), which leads to swelling (edema) and weight gain. Extra body fluid can make some heart problems worse or lead to heart failure. Heart failure means the heart does not pump blood well enough. Patients should not take ACTOS if they have severe heart failure. If patients have heart failure with symptoms such as shortness of breath or swelling, even if these symptoms are not severe, ACTOS may not be right for them. Patients should call their doctor right away if they experience swelling or fluid retention (especially in the ankles or legs), shortness of breath or trouble breathing (especially when lying down), an unusually fast increase in weight, or unusual tiredness.

ACTOS may not be right for everyone. Serious side effects may happen to people taking ACTOS.

Patients should not take ACTOS if they are allergic to any of its ingredients.

ACTOS may cause liver problems. Patients should call their doctor right away if they experience nausea, vomiting, stomach pain, unusual or unexplained tiredness, loss of appetite, dark urine, or yellowing of the skin or eyes, as these could be symptoms of liver damage.

Women are at higher risk of having broken bones (fractures) while taking ACTOS.

There may be an increased chance of having bladder cancer when patients take ACTOS. Patients should not take ACTOS if they are receiving treatment for bladder cancer. Patients should tell their doctor right away if they have blood or a red color in the urine, have an increased need to urinate, or have pain while they urinate, as these may be symptoms of bladder cancer.

When taking ACTOS with insulin or other anti-diabetic medications (especially sulfonylureas), hypoglycemia (low blood sugar) may occur. Lightheadedness, shakiness, dizziness, or hunger may mean that a patient's blood sugar is too low. Patients
'/>"/>

SOURCE Takeda Pharmaceuticals U.S.A., Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Takeda Launches New Subsidiary in Ecuador
2. Takeda lanza nueva subsidiaria en Ecuador
3. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
4. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
5. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
6. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
9. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
10. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
11. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... MADISON HEIGHTS, Mich. , April 21, 2015 /PRNewswire/ ... national provider of infusion pumps and related services for ... and Canada , announces ... subsidiary of substantially all of the assets of Ciscura ... Alpharetta, GA , was a privately-held ...
(Date:4/21/2015)... 21, 2015 Gary A. Puckrein , ... Quality Forum (NMQF), today will present an award ... Pharmaceutical Research and Manufacturers of America (PhRMA), for ... On behalf of PhRMA, and in conjunction with NMQF, ... build awareness, start conversations, and increase diversity in clinical ...
(Date:4/21/2015)...  A new, cutting edge prostate cancer test is ... revolutionize the way prostate cancer is diagnosed.  Dr. ... in Paris, France , performed the ... North Florida / South Georgia ... diagnosis and management to Greater Jacksonville ...
Breaking Medicine Technology:InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 2InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 3InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 4National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 2Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 3
... CHICAGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline ... of pazopanib in,advanced or metastatic renal cell ... (STS). These trials were presented at the,43rd ... Clinical Oncology,(ASCO) in Chicago. The results observed ...
... /PRNewswire/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnologies Corporation today ... oncology and a,definitive benchmark in the emerging field ... its kind, Le Morte du Tumour --,published in ... Vol.30, pp. 1297-1307 -- documents the histologic,features of ...
Cached Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 Grafika ... County commercial printer, Offset Impressions. , “We’re ... full line of printing capabilities and knowledgeable team members,” ... “This acquisition allows us to offer an ever wider ... the labeling, packaging, and specialty services we already offer. ...
(Date:4/21/2015)... 2015 The California Healthcare Institute ... life sciences organizations, released the following statement by ... State Assembly Bill (AB) 463: , “As innovators ... development of treatments and cures for patients with ... regarding AB 463, the so-called Pharmaceutical Cost Transparency ...
(Date:4/21/2015)... Information is the best weapon in the ... empowers patients and their families with knowledge about living with ... Cancer is the Answer" and new website . , ... guide patients from diagnosis through treatment and even death. The ... their treatment, at home and in the examination room. , ...
(Date:4/21/2015)... April 21, 2015 The ... provides comparative analysis on the therapeutic development ... pipelines by identifying new targets and MOAs ... report with TOC is available @ ... reviews key players involved in the therapeutic ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Global Sodium Citrate Industry is a professional and ... global Sodium Citrate Market with a ... companies included in the sodium citrate market research ... Acid Chemicals, Natural Biological, Cofco Biochemical, Capchem, Lianyungang ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
... MONDAY, Jan. 17 (HealthDay News) -- Conventional wisdom says that ... day and help prevent overeating at other meals, but a ... Schusdziarra, a researcher with the Else-Kroner-Fresenius Center of Nutritional Medicine ... included 280 people who were obese and 100 who were ...
... SATURDAY, Jan. 15 (HealthDay News) -- Cigarettes start to ... research indicates, suggesting that the habit causes immediate genetic ... "The results reported here should serve as a ... smoke cigarettes," lead study author Stephen S. Hecht, from ...
... 17 (HealthDay News) -- Among middle-school students, friendships can ... have found. Students whose friends are socially active ... friends who behave badly get lower grades, according to ... "pro-social" friends and also staying away from deviant peers ...
... a step closer to developing a vaccine to prevent ... joint surgery. Other MRSA vaccine research has failed ... the inability to identify an agent that can break ... has targeted the surface of the bacteria, but the ...
... , SATURDAY, Jan. 15 (HealthDay News) -- Five simple ... says a leading expert on preventive cardiology. About ... to be done to educate people about risk factors ... and outreach at the Ronald O. Perelman Heart Institute ...
... HealthDay Reporter , FRIDAY, Jan. 14 (HealthDay News) ... to raise the risk of cardiovascular disease, while also ... against heart attack once arteries become clogged. "Certain ... genes lead to heart attack when you already have ...
Cached Medicine News:Health News:Smoking Damages DNA Within Minutes, Research Shows 2Health News:Friends a Big Influence on Grades in Middle School: Study 2Health News:Researchers unzip MRSA and discover route for vaccine 2Health News:Researchers unzip MRSA and discover route for vaccine 3Health News:Five Steps to a Healthier Heart 2Health News:Blood Type O Associated With Less Risk for Heart Attack 2Health News:Blood Type O Associated With Less Risk for Heart Attack 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: